Posted by Michael Wonder on 11 Apr 2019
On rising insulin prices, law maker tells pharma execs: 'Your days are numbered'
10 April 2019 - Lawmakers tensed with frustration, some clenching their jaws, while grilling a panel of pharmacy and pharmaceutical company executives about the soaring cost of insulin during a congressional hearing on Wednesday.
The tension could be felt as some executives fidgeted in their chairs while answering lawmakers' questions.
The hearing, held by the House Committee on Energy and Commerce's Oversight and Investigations Subcommittee on Capitol Hill, was the second this month to examine how fast-rising insulin costs affect diabetes patients across the United States.
The average price of insulin tripled over the course of a decade, from $4.34/mL in 2002 to $12.92/mL in 2013, according to a study published in the medical journal JAMA in 2016.
